REGISTERED
on 14 Jun 2022
Last Applicant/ Owned by
1040 Spring Street
Silver Spring
MD
20910
Serial Number
90370409 filed on 09th Dec 2020
Registration Number
6756715 registered on 14th Jun 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
TYVASO DPI (TREPROSTINIL) INHALATION POWDER
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins
First Use Date in General
28th Oct 2020
First Use Date in Commerce
28th Oct 2020
Mark Details
Serial Number
No 90370409
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 080618-
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Jun 2022 | REGISTERED-PRINCIPAL REGISTER |
| 14th Jun 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Mar 2022 | PUBLISHED FOR OPPOSITION |
| 29th Mar 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Mar 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 18th Feb 2022 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| 17th Feb 2022 | USE AMENDMENT ACCEPTED |
| 17th Feb 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 16th Feb 2022 | ASSIGNED TO LIE |
| 16th Feb 2022 | EXAMINER'S AMENDMENT ENTERED |